Advances in management of movement disorders in children

Area of Science:

• Neurology
• Pediatrics
• Developmental Neuroscience

Background:

• Pediatric movement disorders exhibit significant heterogeneity in cause and presentation.
• Current treatments, including pharmacotherapy and advanced interventions, show variable and often temporary effects.
• Limited randomized controlled trials exist for pediatric populations, highlighting an unmet need for evidence-based management.

Purpose of the Study:

• To address the unmet need for effective and sustained therapeutic options for pediatric movement disorders.
• To emphasize the importance of translating current knowledge into novel treatment development.
• To advocate for rigorous clinical trials in pediatric populations.

Main Methods:

• Review of existing literature on pediatric movement disorders and current treatment strategies.
• Analysis of the challenges in assessing therapeutic efficacy in a developmental context.
• Discussion of the need for pathophysiology-informed treatment development and trial design.

Main Results:

• Current treatment options for pediatric movement disorders are diverse but often lack sustained efficacy.
• Few interventions have been validated through age-appropriate randomized controlled studies.
• Understanding the pathophysiology is crucial for developing targeted and effective therapies.

Conclusions:

• Effective therapeutic options for pediatric movement disorders remain an unmet need.
• Translating research into novel symptomatic or disease-modifying treatments is vital.
• Well-designed clinical trials are essential for assessing new therapeutic strategies in children.